
<DOC>
<DOCNO>
WSJ900530-0043
</DOCNO>
<DOCID>
900530-0043.
</DOCID>
<HL>
   Duramed Pharmaceuticals Inc.
</HL>
<DATE>
05/30/90
</DATE>
<SO>
WALL STREET JOURNAL (J), NO PAGE CITATION
</SO>
<CO>
   DRMD
</CO>
<LP>
   CINCINNATI -- Duramed Pharmaceuticals Inc. said it signed
a joint-venture agreement with Atral/Cipan, giving Duramed
the U.S. marketing rights to the Lisbon, Portugal-based
antibiotics maker's drugs that have been approved by the U.S.
Food and Drug Administration, including Amoxicillin,
Cephalexin and Tetracycline. Terms weren't disclosed.
</LP>
<TEXT>
</TEXT>
</DOC>